Topical NSAIDs vs topical placeboSerious adverse events · adults with strains, sprains, or muscle pull1 finding from 1 reviewTopical NSAIDs for acute musculoskeletal pain in adults 2015 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow
Celecoxib vs naproxenSerious adverse event · children and adolescents with chronic non‐cancer pain1 finding from 1 reviewNon‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 242 participantsVery low
Rofecoxib vs naproxenSerious adverse event · children and adolescents with chronic non‐cancer pain1 finding from 1 reviewNon‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 310 participantsVery low
Meloxicam vs naproxenSerious adverse event · children and adolescents with chronic non‐cancer pain1 finding from 1 reviewNon‐steroidal anti‐inflammatory drugs (NSAIDs) for chronic non‐cancer pain in children and adolescents 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 225 participantsVery low
Intervention not reportedSerious adverse events · people with cancer pain1 finding from 1 reviewOral nonsteroidal anti‐inflammatory drugs (NSAIDs) for cancer pain in adults 2017 · Cochrane Headline outcomes onlyno estimate extracted11 studies · 949 participantsVery low
Intervention not reportedSerious adverse events · adults with chronic musculoskeletal pain (osteoarthritis)1 finding from 1 reviewTopical NSAIDs for chronic musculoskeletal pain in adults 2016 · Cochrane Headline outcomes onlyno estimate extracted30 participantsVery low